SANGAMO THERAPEUTICS, INC. (SGMOQ)

0.16USD -5.88% (-0.01)

Over 1M: +45.5%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.12 0.15 0.17
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '21 — Revenue: 27.9M Q2 '21 — Operating Income: -48.7M Q2 '21 — Free Cash Flow: -59.8M Q3 '21 — Revenue: 28.6M Q3 '21 — Operating Income: -48.4M Q3 '21 — Free Cash Flow: -64.6M Q4 '21 — Revenue: 28M Q4 '21 — Operating Income: -39.9M Q4 '21 — Free Cash Flow: -55.6M Q1 '22 — Revenue: 28.2M Q1 '22 — Operating Income: -45.3M Q1 '22 — Free Cash Flow: -61.8M Q2 '22 — Revenue: 29.4M Q2 '22 — Operating Income: -45.7M Q2 '22 — Free Cash Flow: -59.4M Q3 '22 — Revenue: 26.5M Q3 '22 — Operating Income: -54.9M Q3 '22 — Free Cash Flow: -58M Q4 '22 — Revenue: 27.2M Q4 '22 — Operating Income: -55.4M Q4 '22 — Free Cash Flow: -64.5M Q1 '23 — Revenue: 158M Q1 '23 — Operating Income: 18M Q1 '23 — Free Cash Flow: -76.5M Q2 '23 — Revenue: 6.8M Q2 '23 — Operating Income: -123.6M Q2 '23 — Free Cash Flow: -66.3M Q3 '23 — Revenue: 9.4M Q3 '23 — Operating Income: -106.4M Q3 '23 — Free Cash Flow: -50M Q4 '23 — Revenue: 2M Q4 '23 — Operating Income: -62.1M Q4 '23 — Free Cash Flow: -53.2M Q1 '24 — Revenue: 481K Q1 '24 — Operating Income: -51.5M Q1 '24 — Free Cash Flow: -48.7M Q2 '24 — Revenue: 356K Q2 '24 — Operating Income: -37.1M Q2 '24 — Free Cash Flow: -26.9M Q3 '24 — Revenue: 49.4M Q3 '24 — Operating Income: 10.6M Q3 '24 — Free Cash Flow: 11.6M Q4 '24 — Revenue: 7.6M Q4 '24 — Operating Income: -26M Q4 '24 — Free Cash Flow: -3.5M Q1 '25 — Revenue: 6.4M Q1 '25 — Operating Income: -29.6M Q1 '25 — Free Cash Flow: -26.1M Q2 '25 — Revenue: 18.3M Q2 '25 — Operating Income: -17.9M Q2 '25 — Free Cash Flow: -18.2M Q3 '25 — Revenue: 581K Q3 '25 — Operating Income: -35.6M Q3 '25 — Free Cash Flow: -28.6M Q4 '25 — Revenue: 14.2M Q4 '25 — Operating Income: -38.2M Q4 '25 — Free Cash Flow: -24.4M Q1 '26 — Revenue: 1.4M Q1 '26 — Operating Income: -31.9M Q1 '26 — Free Cash Flow: -19.3M -120M -60M 0 60M 120M 180M
Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26
Revenue Operating Income Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 21.6%
OE margin -283.4%
Oper. margin -357.5%
Accruals -55.0%
EBITDA margin -347.0%
FCF margin -261.8%
OCF margin -261.4%
Profit margin -356.9%
ROA -205.7%
ROCE -1808.8%
Gross margin —
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

4.8
EV/OE 0.38×
EV/Sales -1.1×
P/C 0.64×
FCF yield -136.5%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/B —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.1
RPO / sales 0.012×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.7
ND/EBITDA -2.8
Cash runway 1.1 yr
Debt payback 0.0 yr
Quick ratio 0.7×
F-score 2.6 pts
Cash / Debt —
Debt / Eq —
Equity / Assets —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -22.7%
Sales/sh Y/Y -61.0%
Sales Q/Q -77.6%
Shares change +38.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.